Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other Accumulated Expenses (2021 - 2025)

Rxo (RXO) has disclosed Other Accumulated Expenses for 5 consecutive years, with $10.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 61.54% year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Dec 2025, down 61.54%, and an annual FY2025 reading of $10.0 million, down 61.54% over the prior year.
  • Other Accumulated Expenses was $10.0 million for Q4 2025 at Rxo, down from $12.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $26.0 million in Q4 2024 and bottomed at $5.0 million in Q3 2022.
  • Average Other Accumulated Expenses over 5 years is $11.9 million, with a median of $12.0 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 283.33% in 2024, then tumbled 61.54% in 2025.
  • Year by year, Other Accumulated Expenses stood at $6.0 million in 2021, then surged by 133.33% to $14.0 million in 2022, then fell by 7.14% to $13.0 million in 2023, then skyrocketed by 100.0% to $26.0 million in 2024, then crashed by 61.54% to $10.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for RXO at $10.0 million in Q4 2025, $12.0 million in Q3 2025, and $13.0 million in Q2 2025.